A total of @ patients without symptomatic intracranial haemorrhage on computed tomography after thrombolysis were allocated to two groups : group A ( n = @ ) received antiplatelets @h after recombinant tissue plasminogen activator , regardless of SWI-detected haemorrhage ; group B ( n = @ ) received antiplatelets for patients without SWI-visualised haemorrhage .